INTRODUCTION
Facilitative glucose transport across the plasma membrane is fundamental to mammalian energy metabolism and is mediated by tissue-specific glucose transporter (GLUT) proteins. In cells such as muscle, the transport of glucose across the plasma membrane is rate-limiting for its utilization [1, 2] . To date, seven glucose transporter genes have been identified, designated GLUT1 to GLUT7 [3] . Of these, three isotypes (GLUT1, GLUT3 and GLUT4) are expressed in rat L6 skeletal muscle cells [4, 5] , a cell line that retains many properties of skeletal muscle [6, 7] . In mammalian tissues, GLUT1 is ubiquitously expressed and is thought to provide basal cellular glucose uptake because of its significant localization at the plasma membrane of many cell types [8] . GLUT4 is expressed in insulin-responsive tissues such as fat, and skeletal and cardiac muscle, where it responds to an acute insulin challenge by translocating rapidly from an intracellular-membrane storage site to the plasma membrane [9, 10] . GLUT3 is principally important in neurons and in developing muscle [11, 12] . In mammals, GLUT3 expression is greatest in the brain, placenta and platelets [11, 13, 14] . In humans, GLUT3 may play a role in fetal skeletal muscle glucose transport, since GLUT3 mRNA is present at this stage of muscle development [11] . In culture, GLUT3 is expressed only in the L6 muscle and UMR 106-01 osteosarcoma cell lines [15] . L6 cells allow for the identification of the particular role of this transporter in comparison with those of the well characterized GLUT1 and GLUT4 transporters. also insensitive to cycloheximide, paralleling the response of glucose uptake, whereas the rise in GLUT1 protein levels was blocked by the inhibitor. The GLUT3 glucose transporter may therefore provide the majority of the glucose transport stimulation by DNP, despite elevated levels of GLUT1 protein. The half-lives of GLUT3 and GLUT1 proteins in L6 myotubes were determined to be about 15 h and 6 h respectively. DNP prolonged the half-life of both proteins. After 24 h of DNP treatment, 88 % of GLUT3 protein and 57 % of GLUT1 protein had not turned over, compared with 25 % in untreated cells. We conclude that the long-term stimulation of glucose transport by DNP arises from an elevation of GLUT3 protein content associated with an increase in GLUT3 protein half-life. These findings suggest that disruption of the oxidative chain of L6 muscle cells leads to an adaptive response of glucose transport that is distinct from the insulin response, involving specific glucose transporter isoforms that are regulated by different mechanisms.
Many mammalian cells have the capacity to adapt to situations of high energy demand by increasing their rate of glucose uptake. Such situations include environmental stress and metabolic challenges to the oxidative chain, such as exercise, hypoxia and mitochondrial inhibition. 2,4-Dinitrophenol (DNP) is an uncoupler of oxidative phosphorylation which rapidly decreases cellular ATP levels [16] . However, cells adapt to this and other stressors by elevating glucose transport in order to increase the anaerobic production of ATP [17] . The anabolic hormone insulin is a physiological stimulator of glucose transport. The increase in glucose uptake induced by energy stressors and insulin in L6 muscle cells occurs in two stages. The initial phase is associated with a redistribution of GLUT3, GLUT1 and GLUT4 to the cell surface [18] , which reaches a maximum within 15-20 min of stimulation and is maintained for up to 60 min. In the prolonged presence of these activators, renewed effects can be observed as early as 90-120 min, with a further increase in glucose uptake beyond the acute phase. This increase continues for up to 24 h, reaching a maximum of 4-fold, and is known to result from an elevated cell content of GLUT3 and GLUT1 proteins, but not of GLUT4 protein [19, 20] .
The regulation of glucose transport activity in the adaptive biosynthetic response to environmental signals and hormones is complex, and evidence has accumulated for regulation of glucose transporters at the transcriptional, post-transcriptional and posttranslational levels in several tissue culture cell lines [21] [22] [23] [24] . For the most part, this phenomenon has been studied extensively for the GLUT1 and GLUT4 isoforms [21, 22, 25, 26] . However, con-siderably less is known about the mechanisms that underlie the regulation of GLUT3 biosynthesis [15, 23, 24, [27] [28] [29] . Given the importance of GLUT3 in neurons [30] and muscle development [12] , it is of interest to characterize mechanisms that regulate its expression.
The present study examined the effects on GLUT3 protein and mRNA levels of prolonged exposure of L6 myotubes to mitochondrial uncoupling in comparison with the effects on GLUT1 expression. The results indicate a unique mechanism of control elicited by metabolic stress that is isoform-specific and, at least for GLUT3, largely post-translational.
EXPERIMENTAL Materials
Tissue culture medium, methionine-free α-minimum essential medium (α-MEM), serum and other tissue culture reagents were obtained from Life Technologies (Burlington, ON, Canada Polyclonal antibody against GLUT1 used for immunoprecipitation was generated as previously described [26] . Polyclonal anti-GLUT1 antibody used for immunoblotting was a gift from Dr. R. Reithmeier (Department of Biochemistry, University of Toronto). Polyclonal anti-GLUT3 antibody was generated as described previously [31] . Monoclonal antibody McK1 to the α " -subunit of the Na + \K + -ATPase was a gift from Dr. K. Sweadner (Massachusetts General Hospital, Boston, MA, U.S.A.). Plasmids containing full-length cDNAs for GLUT1 (prGT4-12), GLUT3 (pmGLUT3-6) and glyceraldehyde-3-phosphate de- 
Cell culture
L6 muscle cells were maintained in myoblast monolayer culture in α-MEM containing 10 % (v\v) fetal bovine serum (FBS) and 1 % (v\v) antibiotic\anti-mycotic solution (10 000 units\ml penicillin G, 10 mg\ml streptomycin and 25 mg\ml amphotericin B) in an atmosphere of 5 % CO # at 37 mC as described previously [32] . Cells were maintained in continuous passage by trypsinization of subconfluent cultures using 0.25 % (w\v) trypsin. Myoblasts were seeded in medium containing 2 % (v\v) FBS at $ 4i10% cells\ml in 10 cm-diameter dishes and used at 6-8 days post-seeding for total membrane preparations, RNA isolation and [$&S]methionine labelling. L6 cells seeded in 12-well plates were used for glucose uptake experiments. Cells were fed fresh medium every 48 h and used at the stage of myotubes.
2-[ 3 H]Deoxyglucose uptake
After various treatments, myotube monolayers were rinsed twice with glucose-free Hepes-buffered saline solution (140 mM NaCl, 20 mM Hepes\Na, pH 7.4, 2.5 mM MgSO % , 5 mM KCl, 1 mM CaCl # ). Glucose uptake was measured as described previously [33] using 10 µM 2-[$H]deoxyglucose (1 µCi\ml) for 5 min at room temperature. Non-specific uptake was determined in the presence of 10 µM cytochalasin B and was subtracted from total uptake. After the uptake period, the radioactive solution was removed and the cells were rinsed three times with cold stop solution (0.9 % NaCl). Cells were lysed in 0.05 M NaOH and cellular radioactivity was quantified by liquid scintillation counting using an LKB 1217 β-radiation counter. Protein content was determined using the Bradford assay [34] . Each condition was assayed in triplicate.
Total membrane preparation and immunoblotting
After the appropriate treatments, total membranes were isolated as described previously [32] and protein content was determined using the bicinchoninic acid assay. Membrane samples (40 µg) were subjected to SDS\PAGE on 10 % gels. Glucose transporter isoforms were detected by immunoblotting as previously described [32] , using polyclonal anti-GLUT3 antibody or polyclonal anti-GLUT1 antibody at a dilution of 1 : 1000, or monoclonal anti-(Na + \K + -ATPase α " -subunit) at 1 : 500 dilution, in 150 mM NaCl, 50 mM Tris\HCl, 1 % (w\v) BSA, 0.04 % Nonidet P-40 and 0.02 % NaN $ (pH 7.5) [5] . Glucose transporter proteins were visualized with "#&I-Protein A for polyclonal antibodies and with "#&I-labelled sheep anti-mouse antibodies followed by Phosphorimager analysis for monoclonal antibody detection.
RNA isolation and Northern blot hybridization
Total RNA was isolated and Northern blots were performed exactly as described previously [19, 35] .
[ 35 S]Methionine labelling and immunoprecipitation of glucose transporters
Labelling of L6 cells with [$&S]methionine and glucose transporter immunoprecipitation was performed essentially according to a previously established procedure [26] . Briefly, L6 myotubes, grown and differentiated in 10 cm-diameter plates, were rinsed twice with PBS, pH 7.4, containing 1 % (v\v) antibiotic\anti-mycotic solution prior to incubation for 2 h in methionine-free α-MEM supplemented with 2 % (v\v) dialysed FBS and 1 % (v\v) antibiotic\anti-mycotic. The medium was removed and myotubes were pulsed for 4 h in fresh methionine-free α-MEM containing 100 µCi of [$&S]methionine\plate. The labelling medium was removed and the cells were rinsed twice with PBS. For chasing, complete α-MEM with or without 0.5 mM DNP or 100 nM insulin was added to the labelled cells for 2-48 h, with medium replaced every 12 h to ensure continuous stimulation. Pulsed-and-chased myotubes were washed twice with cold PBS and lysed in 1.0 ml of 2 % (w\v) C "# E ) \PBS containing 0.4 mM PMSF, 1 µM leupeptin and 1 µM pepstatin A. The cell lysates were transferred to Eppendorf tubes, vortex-mixed vigorously for 1 min and centrifuged at 12 000 g for 15 min at 4 mC. A portion of the supernatants was used for determination of protein concentration and trichloroacetic acid-precipitable radioactivity, and was stored at k80 mC. A 0.9 ml portion of each supernatant was pre-cleared with 10 µl of rabbit pre-immune serum for 1 h at 4 mC with gentle mixing, followed by a 2 h incubation with 25 µl of a 50% (v\v) suspension of Protein A-Sepharose in PBS. Immunocomplexes were collected by centrifuging the mixture for 1 min at 12 000 g in a Microfuge, and the supernatant was used for immunoprecipitation of GLUT3 or GLUT1. Antiserum against either GLUT3 or GLUT1 was added, followed by incubation for 4 h at 4 mC. The immune complexes were collected with Protein A-Sepharose beads as described above and were washed once with 1 ml of Wash I (50 mM Hepes, 1 mM EDTA, 150 mM NaCl and 1 % Nonidet P-40), once with Wash II (Wash I containing 1.0 M NaCl), twice more with Wash I, and finally once with PBS. The immune complexes were incubated in 30 µl of 2i Laemmli sample buffer for 30 min at 37 mC and were separated by SDS\PAGE (10 % gels). Gels were stained with Coomassie Blue, destained and soaked for 30 min in Amplify2. The polyacrylamide gels were then vacuum dried under heat and suction on to filter paper, and exposed to Phosphorimager analysis.
Statistical analysis
Detection and quantification of "#&I and $&S-labelled GLUT isoforms was performed with a Molecular Dynamics Phosphorimager System (Sunnyvale, CA, U.S.A.). Statistical analysis was performed using the ANOVA test (Fisher ; multiple comparisons).
RESULTS

Time courses of GLUT3 and GLUT1 induction by DNP
For all experiments described herein, cells were stimulated with a concentration of 0.5 mM DNP, shown previously to maximally stimulate glucose uptake in L6 myotubes [36] . Cell viability was unaffected at this concentration for up to 30 h. The exposure of L6 myotubes to 0.5 mM DNP caused a rapid and progressive increase in glucose uptake that peaked at 8 h and was sustained for up to 24 h ( Figure 1A) . We have reported previously [20] that incubation with DNP for 18 h elevated the content of GLUT3 and GLUT1 glucose transporters in L6 myotubes. In contrast, no effect on GLUT4 expression was observed [20] . To determine the time course of the induction of GLUT3 and GLUT1, Western blot analysis of the glucose transporter proteins was performed on total membrane fractions from L6 cells incubated for up to 18 h in the presence or absence of 0.5 mM DNP ( Figure  1B ). Representative immunoblots of GLUT3 and GLUT1 are shown in Figure 1(B) , and the results from four experiments are summarized in Figure 1(C) . The DNP-mediated increases in GLUT3 and GLUT1 followed similar time courses. There was a slow phase of increase in GLUT3 and GLUT1, followed by steep increases in both isoforms after 6-8 h of treatment with DNP. However, the effect of DNP on GLUT1 at this time was more pronounced than its effect on GLUT3. After 18 h of exposure to DNP, GLUT3 and GLUT1 proteins were elevated by 3-and 5-fold respectively.
GLUT3 and GLUT1 mRNA responses to DNP
It is known that chronic insulin treatment causes an elevation in the levels of GLUT3 and GLUT1 mRNAs in L6 muscle cells, leading to increased expression of the corresponding proteins [16, 20, 37] . To test whether the same phenomenon occurs with prolonged DNP treatment, Northern blot analysis was performed using total RNA extracted from L6 muscle cells treated for 18 h with or without 0.5 mM DNP. Interestingly, in contrast with the effects of insulin (positive control ; Figure 2A ), GLUT3 mRNA 3 H]Deoxyglucose uptake was determined as described in the Experimental section. Glucose transport in untreated cells (time l 0 h) was assigned a value of 1.0, and all other values are expressed in relative units. Each data point represents the meanpS.E.M. for three independently performed experiments. (B) Total membrane fractions from each experimental group were immunoblotted for GLUT3 and GLUT1 as described in the Experimental section. To ensure equality of protein loading, all membranes were also probed for the α 1 -subunit of the Na + /K + -ATPase, a membrane protein whose expression is not altered on continuous exposure to DNP [4, 20] (results not shown). Representative immunoblots for time-dependent changes in GLUT3 and GLUT1 in response to DNP are shown. (C) Immunoblots were quantified and the results are expressed as the meanspS.E.M. of four independent experiments. The content of GLUT3 ($) or GLUT1 (#) protein from untreated cells was assigned a value of 1.0, and all other values are expressed in relative units. Statistically significant compared with untreated control : *P 0.001 ; FP 0.05. levels were unaltered by treatment of L6 myotubes with DNP for 18 h (Figure 2A) . However, continuous exposure to DNP led to an increase in the steady-state levels of GLUT1 mRNA ( Figure  2B ), similar to the effects of insulin ( Figure 2B ). Therefore, although DNP increased GLUT3 protein levels, it did not increase the steady-state levels of GLUT3 mRNA.
Effect of cycloheximide on glucose transporters and glucose transport
To assess the requirement for ongoing protein synthesis in the responses of increased glucose transport and transporter content, L6 muscle cells were treated with the protein-synthesis inhibitor
Figure 2 Steady-state GLUT3 mRNA is not elevated by DNP treatment
Total RNA was isolated from L6 myotubes incubated with 0.5 mM DNP or 100 nM insulin (INS) for 18 h, as described in the Experimental section. Samples of 20 µg of RNA were analysed by Northern blotting using a GLUT3 (A) or GLUT1 (B) riboprobe. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was probed as a loading control (C). The Northern blots of four independent experiments were quantified, and their values are expressed relative to the respective untreated control, which was given the value of 1.
cycloheximide for the duration of DNP challenge. On DNP treatment of L6 myotubes, GLUT3 protein levels remained elevated during co-incubation with 2 µg\ml cycloheximide ( Figures 3A and 3B) , while the increase in GLUT1 protein was completely blocked by the inhibitor (Figures 3A and 3D ). For comparison, the effects of cycloheximide on insulin-mediated GLUT3 and GLUT1 induction were also examined. In contrast with that induced by the uncoupler, the insulin-stimulated elevation in GLUT3 protein was fully prevented by cycloheximide ( Figures 3C and 3B) , as was that in GLUT1 protein ( Figures 3C  and 3D) . The low concentration of cycloheximide used in these experiments (2 µg\ml) did not directly inhibit or activate glucose transport, since basal levels of transporters ( Figures 3B and 3D ) and glucose uptake ( Figure 3E) were not affected by the drug.
As shown in Figure 3E , the majority of glucose transport in response to chronic DNP treatment remained elevated in the presence of 2 µg\ml cycloheximide, yet the insulin-stimulated glucose transport was completely blocked. Thus, in the face of cycloheximide inhibition of protein synthesis, the DNP-stimulated increase of GLUT3 protein was paralleled by the continued elevation of glucose transport.
Effect of DNP on the half-lives of glucose transporters
To assess whether post-translational mechanisms are responsible for the sustained elevation of GLUT3 protein mediated by DNP, we examined the effects of the uncoupler on the rate of degradation of glucose transporter proteins. L6 myotubes were metabolically labelled with [$&S]methionine for 4 h, a time sufficient to substantially label most cellular proteins (results not shown). After chasing for the indicated times with media containing unlabelled methionine in the presence or absence of 0.5 mM DNP, the amount of label associated with glucose transporter immunoprecipitates was determined. Under basal conditions, the profiles of the decay of radiolabel for the two GLUT isoforms were clearly different. In untreated cells the GLUT3 label decreased by 25 % by 8 h of chasing and had dropped to 75 % at the end of the 24 h chase period ( Figure 4B ). In contrast, labelled GLUT1 had fallen by 75 % within 8 h of chase time and remained at this level up to 24 h ( Figure 4D ). The half-lives of GLUT3 and GLUT1 in L6 myotubes were calculated to be 15 h
Figure 3 Induction of GLUT3 protein levels by DNP treatment is insensitive to cycloheximide
Differentiated L6 cells were preincubated for 60 min in the presence (open bars) or absence (filled bars) of 2 µg/ml cycloheximide (CHX), followed by subsequent incubation with 0.5 mM DNP or 100 nM insulin for 18 h with or without the continuous presence of CHX, as required. Total membrane fractions were prepared and subjected to immunoblot analysis as described in the Experimental section. To assess equality of protein loading, all Western blot membranes were also probed for the α 1 -subunit of the Na + /K + -ATPase, expression of which is not altered by continuous exposure to DNP or insulin [4, 20] (results not shown). Representative immunoblots are shown for GLUT3 and GLUT1 from DNP-treated (A) and insulin-treated (C) cells, and the results are quantified in (B) (GLUT3) and (D) (GLUT1) as the meanspS.E.M. of four independently performed experiments. (E) Uptake of 2-[ 3 H]deoxyglucose was determined under the same conditions as described for (A) and (C). Each data bar represents the meanpS.E.M. of triplicate determinations within a representative experiment, independently performed three times. Where error bars are absent, errors are too small to be seen. Significant differences : *P 0.0001, **P 0.05 compared with basal ; FP 0.0001, FFP 0.05 compared with respective control in the absence of cycloheximide.
and 6 h respectively. The half-life of GLUT3 was markedly prolonged by DNP. More than 80 % of the radioactive label remained associated with GLUT3 immunoprecipitates after 24 h of exposure to DNP ( Figure 4B) . After 24 h, the half-life of GLUT1 had also risen with DNP treatment (Figure 4D ), albeit GLUT3 regulation by mitochondrial uncoupling
Figure 4 Long-term DNP treatment leads to an increase in the half-life of GLUT3 protein
L6 myotubes were pulsed and chased in the absence ( ; CON) or presence () of 0.5 mM DNP. Glucose transporters were then immunoprecipitated and separated by SDS/PAGE (10 % gels) as described in the Experimental section. The labelled GLUT3 (A) and GLUT1 (B) immunoprecipitates were quantified by Phosphorimager analysis. Results are expressed as the percentage of 35 S label remaining in glucose transporters compared with that at 0 h of chase time (100 %), and represent meanspS.E.M. of six independent experiments. Pre-immune complexes and immune supernatants contained no immunologically detectable glucose transporters (results not shown). Significantly greater than untreated control : *P 0.0001 ; FP 0.01.
to a lesser extent than that of GLUT3. The actual changes in half-lives could not be calculated directly, since this would require more than 24 h of chasing in the presence of DNP, which would compromise the viability of L6 muscle cells. Nevertheless, the results in Figure 4 show clearly that the degradation of GLUT3 was significantly inhibited by DNP.
DISCUSSION
In this study we have analysed the effects of chronic (18 h) treatment with DNP on GLUT3 and GLUT1 regulation in L6 myotubes, and compared them with the known effects of prolonged insulin treatment. Prior studies have shown that, unlike that mediated by insulin, the increase in glucose uptake mediated by DNP is insensitive to the protein-synthesis inhibitor cycloheximide [16, 38] ; however, the transporter(s) responsible for sustaining glucose transport was not investigated. Here we demonstrate the chronic DNP-mediated elevation of GLUT1 mRNA and protein, suggesting that de no o biosynthesis of this isoform occurred ; hence cycloheximide was able to block the DNP-stimulated elevation of GLUT1. On the other hand, chronic DNP treatment elevated GLUT3 protein in L6 myotubes without changing the steady-state GLUT3 mRNA levels. Moreover, the uncoupler attained this increase independently of transcription or translation of new GLUT3 protein, but rather by a protein stabilization mechanism. Since DNP-stimulated glucose uptake and GLUT3 protein levels remained elevated during co-incubation with cycloheximide, we suggest that GLUT3 makes a significant contribution to the DNP-stimulated component of glucose transport.
GLUT1 may be functionally silent
Interestingly, although chronic DNP treatment elevated both GLUT3 and GLUT1 protein levels, the elimination of the GLUT1 component by cycloheximide had a minimal effect on DNP-stimulated glucose transport ( Figures 3D and 3E) . Lack of correlation between GLUT1 levels and glucose transport has been noted in earlier reports. For example, glucose deprivation of L6 muscle cells augmented GLUT1 mRNA, GLUT1 protein and glucose transport ; the GLUT1 induction was cycloheximidesensitive, but the glucose transport stimulation was not [38] . The inhibitors of oxidative phosphorylation rotenone and azide also have discrepant effects on GLUT1 protein content and glucose uptake in L6 muscle cells [16] . A reasonable explanation of our results could be that the GLUT3 glucose transporter is responsible for the majority of the glucose transport that is stimulated by DNP, irrespective of the elevated GLUT1 protein levels, i.e. GLUT1 is silent during metabolic stress. This conclusion is not without precedent. Nishimura et al. [39] observed that the catalytic efficiency of GLUT4 was far greater than that of GLUT1 when both transporters were co-expressed in Xenopus oocytes. Moreover, Xia and Lo [40] have proposed that GLUT1 protein may normally exist in an inactive form in L6 muscle cells, and that the GLUT3 and GLUT4 isoforms suffice to provide the cell with essential glucose transport activity. It is likely, then, that GLUT3 serves a specific purpose in the metabolic adaptation of L6 muscle cells to stimuli that compromise energy supply, such as disruption of the oxidative chain and glucose deprivation.
Unique regulation of GLUT3
Here we report for the first time that the half-lives of GLUT3 and GLUT1 proteins are approx. 15 h and 6 h respectively in L6 myotubes. Prolonged exposure to DNP reduced the turnover rate of both proteins. The more rapid turnover of the GLUT1 protein compared with the GLUT3 protein in untreated cells accounts for the more evident stabilization of GLUT1 during early hours of chasing in the presence of DNP. However, up until the 8 h time point, the turnover rates of both GLUT1 and GLUT3 proteins in the presence of DNP are similar. By 24 h of DNP treatment, which coincides more closely with the time point examined for all other steady-state GLUT mRNA and protein analyses (e.g. 18 h) in this study, GLUT3 has a much lower turnover rate than GLUT1. This difference could be a result of the much greater intrinsic rate of degradation of GLUT1 than of GLUT3 seen in the untreated cells. The experimental design of the [$&S]methionine pulse-chase labelling eliminates a protein synthesis component. Thus DNP induces only a moderate stabilization of the GLUT1 protein, while inducing a marked stabilization of the GLUT3 glucose transporter in L6 myotubes. Previous reports examining the effects of energy demand (glucose deprivation) and insulin on glucose transporter turnover have focused on GLUT4 and GLUT1 in 3T3-L1 cells [21, 26, 41] . In those studies, insulin was shown to increase the rate of degradation of GLUT4 and GLUT1, while nutrient depletion led to increased stability of GLUT1, in 3T3-L1 adipocytes. We have observed that insulin increases GLUT3 and GLUT1 halflives only slightly in L6 myotubes (results not shown). Moreover, in adipocytes from fasting rats, the GLUT4 degradation rate was also increased [42] . Therefore the regulation of glucose trans-porter half-life is different in muscle and fat cells, and is isoformspecific.
Elevations in GLUT1 mRNA and protein have been reported in response to chronic stimulation with energy stressors, such as hypoxia and ischaemia, and with insulin in the brain [22, 23] and glucose deprivation, hypoxia and mitochondrial uncouplers\ inhibitors in muscle [16, 36, 38] , fat [16, 43] and other tissues and cell lines [44, 45] . For the most part, GLUT1 expression is controlled pre-translationally, and the effects of insulin or other stimuli result from increased mRNA stability [25, 37, 46] or enhanced rates of transcription [38, 47] , as well as from enhanced protein synthesis [26] , and do not involve mechanisms that stabilize glucose transporter proteins. Our present observations of the effects of DNP on GLUT1 expression are in good agreement with these previous studies. Compared with that of GLUT1, relatively little is known about how the expression of GLUT3 is regulated. Physiological changes such as hypoxia\ ischaemia, chronic hypoglycaemia and starvation have been shown to induce GLUT3 protein in the immature rat brain [23] and rat brain neurons [22] , and to increase GLUT3 mRNA in mouse brain [29] . It has also been reported that chronic insulin increased GLUT3 protein and mRNA in L6 muscle cells [4, 20] and UMR 106-01 osteosarcoma cells [15] . However, the cellular mechanisms responsible for mediating these changes in GLUT3 expression are unknown. We propose a unique mechanism of regulation whereby chronic metabolic challenge elicits GLUT3 protein stabilization.
In conclusion, the increases in the levels of GLUT3 and GLUT1 proteins mediated by mitochondrial uncoupling occur by distinct mechanisms ; the expression of the latter is governed largely by pre-translational processes, whereas the elevation of GLUT3 is determined by increasing the half-life of the protein.
In contrast with DNP, the hormone insulin regulates both transporters by similar protein-synthesis-dependent processes. These studies extend our understanding of the need for the expression of multiple glucose transport proteins in the same tissue for the regulation of glucose and energy homoeostasis.
